Patent Assignment
Reel/Frame 061092/0404
Assignment of Assignor's Interest
Recorded: 2022-09-14
Pages: 7
Assignors
YAO, YIHONG
Executed: 2021-03-21
HUANG, JIAQI
Executed: 2021-03-19
YAO, XIN
Executed: 2021-03-20
ZHU, SHIGUI
Executed: 2021-03-22
Assignees
CELLULAR BIOPHARMACEUTICAL GROUP HK LTD.
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
BUILDING 3, 85 FALADI ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE,PUDONG NEW AREA, SHANGHAI, 201210, CHINA
WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
1699 HUISHAN ROAD, BUILDING 7, 1ST FLOOR A AREA, WUXI HUISHAN ECONOMIC DEVELOPMENT ZONE, WUXI, JIANGSU, 214174, CHINA
CELLULAR BIOMEDICINE GROUP INC.
9605 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Covered Property
(1)
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Applications Thereof
Application:
17/911,524 →
Publication:
US 2023/0212255
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 14, 2022
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0494 →
Assignment of Assignor's Interest
Sep 14, 2022
From: WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0545 →
Assignment of Assignor's Interest
Sep 14, 2022
From: CELLULAR BIOMEDICINE GROUP INC.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0613 →
Assignment of Assignor's Interest
Sep 14, 2022
From: LI, YANFENG; WEI, YUTIAN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0709 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →